Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Vanguard International Dividend Appreciation ETF | VIGI | 22. nov 2024 | 82.58 | +0.83 |
Vanguard International High Dividend Yield ETF | VYMI | 22. nov 2024 | 70.12 | +0.07 |
Vanguard Short-Term Inflation-P | VTIP | 22. nov 2024 | 48.87 | +0.02 |
Vanguard Total International Bo | BNDX | 22. nov 2024 | 50.04 | +0.24 |
Varex Imaging | VREX | 22. nov 2024 | 16.64 | +0.79 |
Varonis Systems | VRNS | 22. nov 2024 | 50.02 | -0.36 |
Vast Renewables | VSTE | 22. nov 2024 | 1.65 | +13.79 |
Vasta Platform | VSTA | 22. nov 2024 | 2.53 | +0.80 |
Vaxart | VXRT | 22. nov 2024 | 0.60 | +0.12 |
Vaxcyte | PCVX | 22. nov 2024 | 88.54 | +0.17 |
VCI Global | VCIG | 22. nov 2024 | 1.98 | -8.14 |
Veea | VEEA | 22. nov 2024 | 2.52 | 0.00 |
Veeco Instruments | VECO | 22. nov 2024 | 27.40 | +3.24 |
Veeva Systems A | VEEV | 22. nov 2024 | 216.58 | +0.95 |
Velo3D | VLD | 22. nov 2024 | 1.35 | 0.00 |
Velocity Financial | VEL | 22. nov 2024 | 20.37 | +0.39 |
Ventas | VTR | 22. nov 2024 | 63.55 | -1.17 |
Ventyx Biosciences | VTYX | 22. nov 2024 | 1.85 | +6.94 |
Venus Concept | VERO | 22. nov 2024 | 0.33 | +12.15 |
Veon ADR | VEON | 22. nov 2024 | 31.35 | +1.13 |
Vera Bradley | VRA | 22. nov 2024 | 5.22 | -0.95 |
Vera Therapeutics A | VERA | 22. nov 2024 | 48.31 | +2.72 |
Veracyte | VCYT | 22. nov 2024 | 39.59 | +1.67 |
Veralto | VLTO | 22. nov 2024 | 106.41 | +0.38 |
Verastem | VSTM | 22. nov 2024 | 4.00 | +1.78 |
Verb Technology | VERB | 22. nov 2024 | 8.94 | +8.50 |
Verde Clean Fuels | VGAS | 22. nov 2024 | 4.17 | -2.11 |
Veren | VRN | 22. nov 2024 | 5.43 | +0.56 |
Vericel | VCEL | 22. nov 2024 | 59.11 | +4.23 |
VerifyMe | VRME | 22. nov 2024 | 0.62 | -11.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.